NIKE CARE LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Nike Care Limited. The company was founded 8 years ago and was given the registration number 10254238. The firm's registered office is in LONDON. You can find them at 85 Dongola Road, , London, . This company's SIC code is 86210 - General medical practice activities.

Company Information

Name	:	NIKE CARE LIMITED
Company Number	:	10254238
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active - Proposal to
Incorporation Date	:	28 June 2016
End of financial year	:	30 June 2019
Jurisdiction	:	England - Wales
Industry Codes	:	86210 - General medical practice activities

Office Address & Contact

Registered Address	:	85 Dongola Road, London, England, N17 6EB
Country Origin	:	ENGLAND
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

Company Officers

Personal Information	Role	Appointed	Status
Flat 58, Arundel Court, Lansdowne Road, N17 0lr, United Kingdom, N17 0LR	Director	28 June 2016	Active

People with Significant Control

Mr Martin Uchenna Ugwu
Notified on	:	27 June 2017
Status	:	Active
Date of birth	:	July 1979
Nationality	:	Nigerian
Country of residence	:	England
Address	:	85, Dongola Road, London, England, N17 6EB
Nature of control	:	Ownership of shares 75 to 100 percent Ownership of shares 75 to 100 percent as trust Ownership of shares 75 to 100 percent as firm Voting rights 75 to 100 percent Voting rights 75 to 100 percent as trust Voting rights 75 to 100 percent as firm Right to appoint and remove directors Right to appoint and remove directors as trust Right to appoint and remove directors as firm

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (1 year ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (1 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (1 year ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (0 months remaining)